Methuen, MA, United States of America

Pamela McGuinness

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 6.2

ph-index = 2

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 2004-2013

Loading Chart...
Loading Chart...
3 patents (USPTO):

Title: The Innovative Contributions of Pamela McGuinness

Introduction

Pamela McGuinness is a notable inventor based in Methuen, MA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds and methods. With a total of 3 patents to her name, her work has the potential to impact various medical applications.

Latest Patents

Among her latest patents is "Intermediates and methods for making zearalenone macrolide analogs." This patent discloses methods and intermediates useful in the preparation of macrolides, specifically compounds of formula (IV) wherein R-R are defined. Another significant patent is "Immunomodulatory compounds and methods of use thereof." This invention focuses on novel compounds that serve as immunological adjuvants when co-administered with antigens, such as vaccines for bacterial and viral diseases. It also includes formulations and methods for immunization using these compounds.

Career Highlights

Pamela has worked with prominent companies in the pharmaceutical industry, including Eisai R&D Management Co., Ltd. and Eisai Company, Limited. Her experience in these organizations has contributed to her expertise in drug development and innovation.

Collaborations

Throughout her career, Pamela has collaborated with notable colleagues, including Lynn D. Hawkins and Sally T. Ishizaka. These partnerships have likely enriched her research and development efforts.

Conclusion

Pamela McGuinness stands out as an influential inventor in the pharmaceutical sector. Her innovative patents and collaborations reflect her commitment to advancing medical science and improving health outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…